EASD-Novo Nordisk Foundation Diabetes Prize for Excellence
The EASD-Novo Nordisk Foundation Diabetes Prize for Excellence recognises outstanding achievements in research which has led to significant advances in the understanding, prevention or treatment of diabetes or its complications.
The awardee will receive a personal monetary award accompanied by a monetary award to support the ongoing research of the awardee, generously sponsored by the Novo Nordisk Foundation.The awardee will deliver a Lecture during the EASD Annual Meeting in the year of the award and is expected to provide annual reports on the research supported by the Prize for up to 5 years after receipt of the award.
2025 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence Recipient
Mathieu (left), Shulman (middle) & Novo Nordisk Foundation Representative (right)
Prof. Gerald I. Shulman, USA
Targeting mitochondria to treat type 2 diabetes and cardiometabolic disease
EASD-Novo Nordisk Foundation Diabetes Prize for Excellence Awardees:
2025 Vienna
G.I. Shulman (US): Targeting mitochondria to treat type 2 diabetes and cardiometabolic disease
2024 Madrid
J.R. Zierath (SE): Deconvoluting signals and metabolic rhythmicity of insulin- and exercise-action in type 2 diabetes
2023 Hamburg
R. Hovorka (UK): Automated insulin delivery - diabetes tech at its best
2022 Stockholm
A.-G. Ziegler (DE): Starting the clock to type 1 diabetes
2021 Virtual Meeting
J.A. Todd (UK): From HLA-DQ position 57 and back again
2020 Virtual Meeting
J.C. Brüning (DE): Brain insulin action in CNS-dependent control of metabolism
2019 Barcelona
D.J. Drucker (CA): Alimentary antidotes for amelioration of metabolic maladies
2018 Berlin
G.S. Hotamisligil (US): A quarter century of immunometabolism
2017 Lisbon
P.E. Scherer (US): The many secret lives of adipocytes: implications for diabetes
2016 Munich
A. Hattersley (UK): Defining heterogeneity in diabetes to improve clinical care
2015 Stockholm
S. O'Rahilly (UK): Human metabolic disease: lessons from genetics
